Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Wnt signaling pathway is a highly conserved group of signal transduction pathways that play essential roles in embryonic development, cell fate determination, proliferation, migration, polarity, organogenesis, and adult tissue homeostasis. The pathway is initiated by Wnt ligands binding to Frizzled receptors and co-receptors like LRP5/6, leading to activation of downstream signaling cascades. These cascades include the canonical (Wnt/β-catenin) pathway, which regulates gene transcription, as well as non-canonical pathways involved in planar cell polarity and calcium signaling. Aberrant activation of the Wnt pathway is implicated in various diseases, including cancer.
Various, depending on the specific drug and component targeted within the pathway. Examples include inhibiting Wnt ligand secretion, blocking Wnt-receptor interactions, or disrupting downstream signaling components like β-catenin.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wingless-related Integration Site Signaling Pathway (WNT).